We need to evaluate the transcript against two gates. Gate 1: Is there a positive current development that management presents as going well, and does the Q&A produce more concrete operating detail than the prepared remarks? Gate 2: Is the primary engine of that development something the company itself created and controls? Let's analyze the call. The main positive current development is the advancement of CLS-AX, particularly the Odyssey trial that is about to open for enrollment. Management announces that the study will open for enrollment in the next few weeks and expect first patient shortly. Also, they discuss the OASIS trial results presented at ARVO. But the question is about a current development that analysts probe in Q&A. The Q&A focuses on the Odyssey trial design, endpoints, treatment burden, etc. However, the prepared remarks already gave a lot of detail about the trial design. In the Q&A, analysts ask about non-inferiority margins, treatment burden, etc. Management answers with some specifics but largely repeats the design and rationale. For example, when asked about what would be a meaningful result, George says they hope all patients go at least four and vast majority to six months. That's a target, not a current operational detail. The Q&A does not seem to add new concrete operating details about the trial's progress, such as number of sites, enrollment numbers, or any actual activity beyond what was already stated. The prepared remarks already said the study will open in next few weeks and target 30 sites. The Q&A does not add more specifics about that. The analysts ask about trial design and endpoints, but management's answers are more about rationale and hopes, not about actual current execution. There is no mention of any new data, any actual enrollment, or any operational metrics that were not already in the prepared remarks. So Gate 1 likely fails because the Q&A does not produce more concrete operating detail than the prepared remarks. The prepared remarks already had the trial design, the OASIS results, the partnership updates, etc. The Q&A is mostly about clarifying the design and what would be considered success, which is more about future expectations than current operations. Also, the development is the trial initiation, which is a plan, not yet actual activity. The trial is about to open, but no patients enrolled yet.
Clearside Biomedical, Inc.
The call grade, management's tone measured against 177,437 other calls, what changed since the quarter before, and every one of the 500 checks.
This is the current report. Unlock its call read, expected move size, and all 500 answers.
- Does the transcript contain the phrase "next question" at least twice?
- Does an analyst preface a question with "quick" or "quickly"?
- Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
- Does management say "we are not going to comment on" or equivalent refusal language?
30 markers, measured against 177,437 calls
Language counted straight from the transcript, behaviour read by the 500 checks, tone above. The band is the middle half of every call we have graded; a flag means this call sits outside it.
All 500 AI checks
Q4 2023 · 500 checks
Every answer is below. Open any check to see what its YES or NO means.
YES Does an executive answer a question by describing a process rather than an outcome?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question the executive answers with a question back to the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone compare the company to an unnamed "competitor" or "peer" rather than naming it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use "historically" or "traditionally" while defending a current practice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a departure, transition, or role change mentioned only in passing without a thank-you or tribute?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference a private conversation ("as I told...", "as we discussed offline")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the phrase "next question" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question spanning more than five sentences?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question containing multiple sub-questions (three or more)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO answer a question personally after another executive initially responds?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst preface a question by summarizing the company's stated results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "obviously" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "guidance" in the same sentence as a specific number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "congrats" or "congratulations" to management?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "scale" or "scaling" used as a verb?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question beginning with a number ("two questions", "three quick ones")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "thank you" before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst name two or more executives when asking their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "outperform," "outperformance," or "beat" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "the environment" when describing market conditions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive begin an answer with "Great question," "Thanks," or "Appreciate"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the phrase "adjusted" or "non-GAAP" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "with that" as a transition phrase?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a comparable basis" or "adjusted for"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "moving to" or "turning to" when changing topics?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "over to you" or "I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "operator" aloud during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone repeat the same stock phrase three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "as you know" to introduce a claim?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker apologize without attaching a fix to the apology?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the call end without any closing statement from the CEO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a request to move the call along or to the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive answer a question with another question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive mention the weather?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a negotiation currently in progress?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive describe a competitor with anything resembling respect?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator announce more than ten questioners in the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "kind of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question include the word "color"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO deliver the opening remarks rather than the CFO or IR head?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "if I may" or "if you don't mind"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive's first sentence include the word "revenue"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst use the word "clarification" or "clarify" in a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question contain the phrase "color on" or "some color"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator use the phrase "our final question" before closing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "let me" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "aggressive" or "aggressively" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question referencing "the puts and takes"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "to be clear"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst's question include a compliment followed by "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "sequential" or "sequentially" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "with that" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "for the benefit of" or "just to remind" when restating context?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "early days"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "journey" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the speaker describe a strategy as "disciplined" without describing any trade-off?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an apology offered to a specific analyst by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be honest" or "frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone promise to "follow up" or "take that offline" and fail to commit to when?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone on the call interrupt a colleague mid-sentence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does someone use a personal anecdote rather than a metric to justify confidence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "question" appear in the operator's speech more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "growth" appear at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a couple of"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation or buybacks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "strong" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "we're seeing" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "confident" or "confidence" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "record" appear at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "team" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management promise to follow up or take a question offline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we're excited about" or "we're pleased with"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Do two or more analysts from the same firm ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "moving forward" or "go forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention a specific number of stores, locations, or markets?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "folks"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "we believe"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator use the phrase "next question" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst mention a specific percentage figure in their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quarter" appear in at least ten questions or answers during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does at least one analyst ask a question about margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO answer the majority of analyst questions personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question phrased as "Can you talk about" or "Can you speak to"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO speak during the Q&A portion at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question reference a specific quarter (e.g., "fourth quarter") by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator interrupt the Q&A to announce time is limited or that this will be the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question beginning with "just" (e.g., "just curious")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask about a specific dollar amount or number stated in the prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question begin with the words "can you" or "could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "if you look at" during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO answer at least one question without the CEO speaking first?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question containing an explicit comparison to a competitor company?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "moving on" or "next question" come from the operator?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation (capex, buybacks, M&A, or dividends) in one question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "color" appear (e.g., "add some color") in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "I think" at least three times within a single answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive begin an answer by restating the analyst's name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive's answer exceed 300 words in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer the first analyst question personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "obviously" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain the word "margin" more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive begin an answer with "So" as the first word?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "if I may" or "if I could" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "let me" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question contain the word "specifically"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention "margin" or "margins" in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "definitely" used by any speaker?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust" to describe demand, growth, or the pipeline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "leverage" as a verb at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" when referring to employees?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive say "that said" or "having said that" to introduce a caveat?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we remain confident" or "we are confident"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "thank you" immediately after finishing an answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive cite a specific dollar figure greater than one billion?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question contain the word "curious"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst reference a specific prior quarter by name (e.g., "last quarter")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "obviously" two or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a follow-up in the same turn after their first answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific geographic region or market?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question that includes the phrase "long term" or "long-term"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" or "margins" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we'll come back to that" or defer an answer to a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" three or more times in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "free cash flow" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the word "momentum"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO mention at least one specific customer segment by name (e.g., "enterprise")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "take your question" or "take the question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst introduce themselves by name before asking their first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "including" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management reference "the macro environment" or "macroeconomic" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive reference "our team" or "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than one analyst from the same firm?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any prepared remark mention "headwinds" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "with that, I'll turn it over"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the phrase "capital allocation"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive decline to answer, citing that something will come later or is not disclosed?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a two-part question containing the word "but"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone ask a follow-up question in the same turn after their first question is answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone answer "yes" or "no" as the first word of a response?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "thank you" at least ten times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their question with "Hi" or "Hello" as a greeting?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we are excited about" without naming a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst reference a peer company's results or valuation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the phrase "just to clarify" or "just to be clear"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the word "headwind" or "headwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "momentum"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "investments" appear in the context of margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "FX" or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "efficiency" or "productivity" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank the executives or congratulate them before asking a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "great question" or "thanks for the question"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "as we said last quarter" or reference a prior call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "levers" when discussing actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management thank analysts by name at any point after a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we'll take that offline" or offer to follow up after the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "committed" regarding a target?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks mention "macro" or "macroeconomic"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "the vast majority"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "temporary" or "transitory" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is an analyst's question answered with "great question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a questioner from an investment bank other than the first three analysts who ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question that includes a reference to a specific dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you for taking my question" or "thanks for taking my question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's first sentence contain a compliment or thanks before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO present in both the prepared remarks and the Q&A portion of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally deliver the closing remarks of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks contain the word "team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "moving on" or "with that" to transition between topics?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "in terms of" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO First-person singular ("I believe," "I think") used more by the CFO than the CEO.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO A single question receives answers from two different executives.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO A hedge word ("maybe," "sort of") appears inside a direct quantitative claim.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "obviously"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in both prepared remarks and the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive defer a question to another executive by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Someone uses the word "honestly," "frankly," or "to be clear."
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "ecosystem" or "platform" without a number attached?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "certainly" three or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone begin an answer by restating or paraphrasing the analyst's name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst reference a competitor by name during their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker say "let me" at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES The transcript contains an apology unrelated to financial results.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The word "challenge" is spoken more often than "opportunity."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" or "seasonal" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The phrase "as you know" appears at least twice.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "challenge" or "challenges" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "weather" as a factor affecting results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "thank you" to the analyst before answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "great question" or similar praise of a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES The final question is answered noticeably shorter than the opening ones.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we remain" followed by a verb (e.g., "we remain committed")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive cite a conversation with a customer that has no verifiable specificity (unnamed, undated, unquantified)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a sentence that begins with "What I would say is"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question mention a specific percentage or dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more questions than any other executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "our final question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "clearly" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "leverage" appear as a verb at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's first name get used by an executive when thanking them?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than five questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Are there more than ten analyst questions in total?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our next question comes from" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "we are not going to comment on" or equivalent refusal language?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Executive corrects an analyst's premise.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared section exceed the CEO's in number of paragraphs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more than half of the analyst questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention the word "margin" in their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Executive uses the word "excited" more than twice.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a multi-part question containing three or more distinct questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a two-part question signaled by "and also" or "and secondly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst begin with a compliment, such as "great quarter" or "congrats"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we said" when recalling prior statements?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their turn with "thanks" or "thank you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "tailwind" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "synergies" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst address a question to two or more executives by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we feel" rather than "we believe" or "we think"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "capital" appear in at least three different speakers' turns?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive use the phrase "over time" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "as I mentioned" or "as we said" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO open the call before any analyst questions by mentioning the macro environment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are pleased" or "we're excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "leverage" (financial or metaphorical)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "automation" or "productivity" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "uncertainty" or "uncertainties" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "leverage" or "leveraging" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Currency headwinds mentioned unprompted.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "a number of" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "best-in-class" or "industry-leading"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "momentum" appear at least twice in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "on a constant currency basis" or similar currency adjustment used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "just to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "the team" appear at least twice in management remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "so clearly" or "quite frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "we believe" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Speaker says "we don't guide" on anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "quarter" at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear at least twice in the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "typically" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive state they will "come back to" a question or follow up later?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management thank analysts for their questions at any point during Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Speaker admits being surprised by anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "going forward" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "stability" or "stable" when describing demand?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Word "normal" used about demand.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "stay tuned" or "more to come"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management describe a cost program, restructuring, or efficiency initiative by a proper name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section mention interest expense by name or figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "volatility" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Executive mentions a hobby or personal anecdote.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "pipeline" appear without a dollar figure attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "the macro" or "macro environment" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "our team" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" or "good question" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we remain" followed by an adjective?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management thank analysts by name when responding?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "flexibility" or "flexible" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "takeaway," "take out," or "take rate"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Analyst compliments the team before asking a question.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst reference the CEO or CFO by first name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "obviously" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "pipeline" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "moving on" or "let me turn it over" during prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question starting with "just"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "headwind" or "headwinds" more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the phrase "to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "year over year" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a conversation with a customer, partner, or employee as evidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question go to a named executive other than the CEO or CFO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "to be clear" or "let me be clear"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone mention a competitor by name without being prompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a question that management declines to answer directly, citing timing or disclosure constraints?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question explicitly reference the company's prior guidance or outlook?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "next question" or does the operator use the word "final" before the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "invest" or "investment" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO handle a strategic question instead of a financial one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst flatter management within their first sentence of speaking?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask two questions when told to ask only one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "underlying" to modify a business metric?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "excited" or "pleased" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in the prepared remarks (not just Q&A)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "margin" used with a number attached (e.g., "400 basis points")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "record" preceding a noun (e.g., "record margin")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive answer a question by citing a competitor's actions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenges" appear more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO begin an answer with "look" or "listen"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a pause or silence acknowledged on the call ("I think we lost you")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive name a specific competitor during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenges" appear at least three times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we don't break that out" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a metric as "noisy" or "lumpy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention a specific number of percentage points when discussing market share?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does a speaker correct a figure they themselves just stated?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO refer to a competitor by name rather than "competition" or "peers"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO mention their own tenure or years of experience unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "the team" when taking ownership would be natural?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone blame weather, holidays, or calendar quirks unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone cite a personal anecdote involving a customer conversation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a little bit"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the CFO the speaker for at least one analyst question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we're excited" or "we are excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "dividend" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "invest" or "investment" used more than twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "invest" or "investment" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone cite a percentage of revenue from a specific segment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenge" or "challenging" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe cutting discretionary spending like travel or hiring?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "liquidity" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript mention refinancing, maturity dates, or debt coming due?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention selling assets, real estate, or equipment to raise cash?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference "the macro" or "macro environment"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "our customers" rather than naming a customer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript include a question about interest expense or debt service?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "working capital" appear in a context other than a seasonality excuse?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management thank analysts at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference borrowing from a bank or drawing on a credit facility?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "cost" appear in the first ten sentences of prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we remain confident" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention covenants, amendments to loan documents, or lender conversations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "with that" or "that said" to pivot?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive open their first answer by thanking the analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question include the word "capex" or "cash flow"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headline" or "headwinds" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "core" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst's turn contain the word "congratulations"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing "how" and also "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "as we mentioned" or "as I mentioned" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Are there more than eight analyst questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question include a percentage figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question contain the word "guidance"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared remarks exceed 1,000 words?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "if you look at"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer the first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "balance sheet" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO make closing remarks after the Q&A ends?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "structurally" or "secular"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator say "our next question" two or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the final questioner get an explicit closing acknowledgment from the operator ("last question" or similar)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "business as usual" or "as expected" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst preface a question with "quick" or "quickly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive state a specific numeric percentage when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "in terms of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question that clearly annoyed the executive, visible in the reply's abruptness?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear in the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "strong" appear more than five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "thank you" appear more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question containing the word "margin"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "guidance" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "thank you" appear at least ten times anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive begin an answer by restating the analyst's name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask about capital allocation or share repurchases?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenge" or "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a villain—market conditions, regulation, currency—that behaves consistently across the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenging" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "certainly" appear at least once in management's answers?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a personal, warm, or congratulatory question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question the prepared remarks already answered?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quarter" appear at least twenty times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any single analyst ask more than two questions during the whole call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "on a year-over-year basis" or "year over year" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "headwinds" or "tailwinds" used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "confidence" or "confident" spoken by any executive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "call it" or "let's call it" before an estimate?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "coming back" or "circling back" to take a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we believe" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "if you will" or "so to speak"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "appreciate" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "at the end of the day"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone tell a self-contained anecdote with a beginning, middle, and end?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "our team"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain a silence, pause, or "we'll come back to that" that never resolves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a customer, employee, or competitor as a named character with a motive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we're pleased" or "I'm pleased"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a moment of modesty—someone crediting luck or timing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "excited" or "exciting" used by management at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "just" five or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question begin with "Can you" or "Could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quick" or "quickly" appear in three or more analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask for guidance on a metric management did not offer unprompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question about capital allocation (buybacks, M&A, debt, or dividends)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst use the word "clarify" or "clarification"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "obviously" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management refer to a prior call or prior quarter's commentary when answering?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "actually" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive begin an answer with "Look," or "So,"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenging" or "challenges" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator run out of queued questions and close early?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst apologize or preface with "sorry" before asking?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the word "excited" used by the CEO more than the word "confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the phrase "the right" before a noun ("the right team," "the right decisions")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear more than five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "tailwind" or "headwind" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question begin with a compliment or congratulation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst apologize before or during their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Are there more questions about revenue than about costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "on a" four or more times total (e.g., "on a constant currency basis")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive answer begin with "Sure" or "Yes" followed by a comma?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "from a ... perspective" (e.g., "from a margin perspective")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we're not going to" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management decline to answer by citing a future event ("we'll address that in..." or "at our upcoming...")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "quarter" appear at least 20 times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a mention of "FX," "currency," or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "that's right" or "that's correct" to an analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "leverage" used at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwinds" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "great question" or thank the analyst before answering?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone attribute results to "the team" rather than to strategy?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their question with "congratulations"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management at the end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone describe the future with "We believe" more than "We expect"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker say "normal" or "normalized" about conditions that predate any disruption mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "momentum" used without a stated metric attached to it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "macro" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "solid" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an analogy to a machine, engine, or flywheel?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "visibility" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "base case" or "scenario" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we take that seriously" or "we're very focused on"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "to your point" or "as you mentioned" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator say "thank you" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management mention a specific competitor by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management say "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "fundamentally" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "ahead of" precede any mention of guidance or expectations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any single speaker say "right?" as a tag question at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a consistent basis" or "consistently"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker begin a sentence with "To be honest" or "To be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "strategic" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker describe a business unit as "healthy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "fundamentals"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "resilient" or "resilience" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator mention a queue or "next question" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a follow-up after their initial answer ("follow-up", "second one", "just one more")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "if you look at" before citing a number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "last question" or "final question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "clearly" appear anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO speak first among named executives in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "headwinds" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO mention a specific percentage greater than ten?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "team" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "confident" appear in any executive's remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management at the start or end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO use the word "incredibly" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" to refer to company personnel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "to your point" when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "with that" to transition between speakers or topics?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "transformation" or "transformational" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "moving on" or "next question" themselves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "hedging" or say "to hedge"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst identify themselves with a two-part introduction (name and firm)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "talent" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" used more often about factories than about people?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive confess to having too much of something physical somewhere?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a supplier or vendor mentioned by name at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive blame weather, season, or geography for a shipment or delivery issue?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
Archived AI reasoning
Earlier Artul research experiments on CLSD calls. Open a question to read the model's original reasoning.
NO Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development — compa
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to evaluate the transcript for two gates. The main positive current development is the OASIS trial data for CLS-AX, a drug candidate. Management presents it as going well: favorable safety, durability, reduced treatment burden. Analysts probe in Q&A. Do management's answers add more concrete operating detail than prepared remarks? Let's check. Prepared remarks already detailed the data: safety, durability, treatment burden reduction, case studies. In Q&A, analysts ask about Phase 2 design, patient selection, endpoints, etc. Management answers with some specifics but largely reiterate that they are still analyzing data, waiting for final extension study results, and considering options. For example, when asked about dose selection, Tom says "it's premature to comment" and "we're still deciding." When asked about patient population, they say "we're still evaluating." The answers are not adding new concrete operational specifics beyond what was in prepared remarks. They are mostly generalities and future plans. The only new detail might be about the definition of sub-responder, but that's more explanatory than new operational detail. The Q&A does not produce more concrete operating detail than prepared remarks. So Gate 1 is likely NO. Gate 2: The development is the clinical trial results, which is a product candidate. The engine is the company's own drug and delivery system. That is internal. But the question is whether the momentum is from external environment. No, it's internal. However, Gate 1 fails, so overall answer is NO. Thus answer NO.
We need answer only YES or NO. Need evaluate both gates. Need use transcript. Gate 1: positive current development with Q&A adding more concrete operating detail than prepared remarks. Main developments: PEACHTREE enrollment completed, SAPPHIRE enrolling, TYBEE first patient, HULK completed enrollment. Q&A probes: SAPPHIRE enrollment progress, TANZANITE patients rollover, DME rationale, safety, regulatory strategy, commercialization, managed care, training, NDA timing, label. Does Q&A add concrete operating detail? For SAPPHIRE enrollment, Daniel says "commend team... impressed by interest... compared to PEACHTREE, nine-day difference" but no specifics. Glen says TANZANITE patients not eligible. That's not additive about development. DME rationale explained but not new operating detail. Safety discussion general. Commercialization plans general. Training details about loss of resistance, but that's not a current development being probed? It is about product. NDA timing: "second half '18" added. But is that operating detail? Maybe. However Gate 1 requires multiple exchanges adding fresh specifics about a positive current development. The Q&A mostly repeats or general. There is some detail about training, managed care, but not tied to a current development with concrete specifics. Also no specific enrollment numbers beyond already known. So Gate 1 likely NO. Gate 2: main positive development is clinical trial progress. Engine? Company's own execution, but clinical trials are company's own. However Gate 2 asks if momentum chiefly company-created vs external. Clinical trial enrollment is company's own. But if Gate 1 NO, overall NO. Need answer NO. Thus final NO.
NO Call runs ahead of the accounts: the business management describes is already operating beyond the period it is reportin
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if there is a clear gap between the trailing period being reported (Q3 2022) and the level at which the business is already operating right now, as per management's own words. The call is about Clearside Biomedical, a biotech company. The reported period is Q3 2022 financials, but the main focus is on clinical trial data (OASIS trial) for CLS-AX. The company is a development-stage biotech, so revenue is likely minimal. The "business" here is the progress of its drug candidate. Management discusses the OASIS trial results, which are from the trial that was ongoing during the period. They also discuss an Extension Study with interim data. They talk about future plans for a Phase 2 trial. The question is whether management conveys that the company is already operating at a level beyond the reported period. For a biotech, the "business" is the clinical development program. The reported period includes the OASIS trial data? Actually, the earnings call is for Q3 2022, but they are presenting data from the OASIS trial that was likely completed or ongoing. They mention "final data from all four dosing cohorts for the three month endpoint" and "interim data from the Extension Study" with data cut as of October 27, 2022. So the data presented is from the trial that was ongoing during the period, but the results are being reported now. The company is a development-stage company, so the "business" is the progress of its pipeline. The question is whether management describes the company as already having moved beyond the results being presented. For example, they might say that the trial results are from an earlier phase, and they are already planning the next phase, or that the current activity is already at a higher level. But the question is about a gap between the trailing period being reported and the level at which the business is already operating right now. In this case, the trailing period is Q3 2022, and the business is the clinical development. The OASIS trial data is from that period, but the company is already planning Phase 2. However, the call is primarily about presenting the OASIS data. Management is not saying that the reported numbers understate the company; they are presenting the data as the current state. They are also discussing the Extension Study, which is ongoing. They are planning to initiate a Phase 2 trial in Q1 2023.
NO Proven engine, fuel already in the tank: a working growth driver plus already-held means to multiply it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: Does management describe BOTH of the following about the SAME part of the business, as one connected present-tense story? (1) A PROVEN, ALREADY-PRODUCING GROWTH ENGINE THAT IS STILL SMALL RELATIVE TO ITS ROOM. Management identifies a specific driver of growth — a product, service, offering, location type, customer relationship, market, asset, or capability — that is ALREADY generating real business today (actual revenue, orders, customers, volumes, output, or usage in the recent period, described with concrete substance rather than as pipeline, plans, or market opportunity), and management conveys, directly or plainly in substance, that this driver has so far captured only a small part of what it can reach — because it is early in its rollout, present in only a fraction of the customers, sites, applications, or territory available to it, or recently started and still ramping — so that the reported results reflect only the beginning of what this engine is already doing. (2) THE MEANS TO MULTIPLY IT ARE ALREADY IN THE COMPANY'S HANDS. Management describes resources the company ALREADY possesses or has ALREADY secured that it is now using, or beginning to use, to scale that same driver up — in whatever form fits the business: cash or self-generated funds being deployed into it; capacity, facilities, inventory, or supply already built or secured that it can fill; an existing customer base, footprint, network, or channel through which it can be pushed; approvals, qualifications, or positions already held that permit its expansion; a repeatable formula, site type, or playbook already demonstrated that is now being replicated; or people and capability already in place being pointed at it. The multiplication must be presented as already underway or already resourced from what the company has — not dependent on raising outside money, winning approvals not yet obtained, or demand that has not yet appeared. Answer YES when both halves are present in management's own words and connected — the engine is real and producing now, its captured share of its own opportunity is still small, and the company is already applying means it already holds to make it bigger — so that the just-reported numbers describe a company visibly smaller than the one management is already building with its own resources.
NO Operating without a net: management is running the company at a pace only justified if the next leg arrives
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the company, Clearside Biomedical, is operating without a fallback position on a specific part of its business, as described in the transcript. The question asks: does management reveal that the company is currently operating WITHOUT A FALLBACK POSITION on a specific part of its business — that is, has it deliberately arranged its own operations so that it is exposed if a particular near-term development does not go the way management expects, and does management describe this exposure plainly and defend it rather than hedge it away? We need to look for evidence in the transcript that management describes the company as having consumed, committed, or given up its cushion in service of one identifiable part of the business. The exposure must be because management is chasing something specific and already real, and management names the exposure and stands behind it. Let's review the transcript. The company is Clearside Biomedical, a biopharma company developing CLS-AX, a treatment for retinal diseases. The call discusses OASIS Phase 1/2a trial results and future plans. Key points from the transcript: - George Lasezkay (CEO) says: "we reported that our current cash and cash equivalents as of September 30, 2022 totaled $53.4 million. As of now this gives us a financial runway into 2024, and we will be able to further refine our financial runway once we finalize our plans for a randomized controlled CLS-AX Phase 2 Trial." This indicates they have cash runway into 2024, but they are planning a Phase 2 trial. They are not necessarily without a fallback; they have cash. - They discuss the OASIS trial results, which are positive. They are planning to initiate a Phase 2 trial in Q1 2023. - They mention they are actively planning for the initiation of a randomized controlled Phase 2 clinical trial in the first quarter of 2023 in wet AMD and/or diabetic retinopathy. - They have an Extension Study with 8 patients remaining, and they expect to report final data in Q1 2023. - They have a financial runway into 2024, but they will refine once they finalize plans for Phase 2. Is there any indication that they have stripped their own slack? For example, are they running low on cash? They have $53.4 million, which gives runway into 2024. That seems like a normal buffer for a biotech. They are not describing a situation where they have no fallback.
NO Secure base, several live doors: core not in question, multiple distinct expansion avenues already producing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management speaks from a secure, settled core business while also describing more than one distinct avenue of additional growth beyond that core, each already real and producing early results. First, identify the core business. Clearside Biomedical is a biopharma company focused on developing treatments for eye diseases using its SCS Microinjector. The core business appears to be the development of CLS-AX (axitinib) for retinal diseases, and also the commercial product XIPERE for uveitic macular edema. The call is about Q3 2022 earnings and the OASIS trial results for CLS-AX. Management discusses the OASIS trial data, which is a Phase 1/2a trial. They are planning a Phase 2 trial. The core business is the development of CLS-AX. Is the core business secure and settled? The call is largely about presenting positive data from the OASIS trial, which is a clinical trial, not a commercial product. The company has a product XIPERE that is commercially launched, but the call focuses on CLS-AX. The core business might be the development pipeline, but it's not a settled, performing business in the sense of generating revenue from a main product. However, the question asks if management speaks from a secure, settled core business that it is not defending or fixing. The call is about presenting positive clinical data, not about defending a weak core. The company has cash runway into 2024. The core is the development of CLS-AX, which is progressing well. So the base is not in question. Now, are there multiple distinct avenues of growth beyond that core? The company is planning a Phase 2 trial in wet AMD and/or diabetic retinopathy. That is one avenue. But is there another? They also have XIPERE, which is a commercial product for uveitic macular edema. That is a different product. But is XIPERE described as an avenue of growth? The call mentions XIPERE as a validation of the SCS Microinjector, but not as a growth avenue. The focus is on CLS-AX. The company also mentions potential for other indications. But are these described as already real and producing results? The OASIS trial is producing results, but that's the core development. The Phase 2 trial is planned, not yet started. The extension study is ongoing. So the only real avenue beyond the core is the potential for CLS-AX in different indications, but that's still the same product.
NO Betting on a customer they cannot yet name: management describes committing real resources to a counterparty relationshi
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to analyze the transcript for the specific criteria. The question asks about a commercial relationship or piece of business whose counterparty is deliberately unnamed or partially described, with a reason given, and the company is already committing real resources, and the payoff is ahead and significant. Let's review the transcript. The call is about Clearside Biomedical, a biopharma company. They discuss CLS-AX, a drug for retinal diseases. They mention partnerships? They mention XIPERE, which is a product. They mention the SCS Microinjector. They talk about clinical trials. They mention Dr. Khanani as a consultant? No, he's a physician providing insights. Is there any mention of a counterparty that is unnamed? They talk about "our SCS Microinjector" and "XIPERE" which is a product. They might have a partner for commercialization? Let's search for any mention of a partner, licensee, or undisclosed entity. In the transcript, they mention "the launch of XIPERE" and "commercially accepted by retina physicians." They don't mention a partner. They might have a collaboration? They talk about "our CLS-AX program" and "future clinical trials." They don't mention any specific counterparty that is unnamed. They mention "we are actively planning for the initiation of a randomized controlled Phase 2 clinical trial" - that's internal. They mention "we have a financial runway into 2024" - no counterparty. They mention "we will be able to further refine our financial runway once we finalize our plans" - no. They mention "we are very pleased to have Dr. Arshad Khanani with us" - he's a physician, not a business counterparty. They mention "we have an active investment conference schedule" - not a counterparty. There is no mention of a customer, partner, licensee, or any entity that is deliberately unnamed. The only possible thing is "XIPERE" which is a product, but they don't mention who they partner with for that. However, they don't say "we have a partner we cannot name" or anything like that. They just talk about the product. Also, they don't describe any relationship where they are committing resources to an unnamed counterparty. They are committing resources to their own clinical trials. Thus, the answer is NO. Let's double-check: The question asks for a situation where management deliberately withholds the identity of a counterparty with a reason.
NO Crossed from claiming to demonstrating: management marks its own before/after line with repeated, recent proof
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the criteria. The question asks whether management conveys that the company has recently crossed from claiming something to demonstrating it, with a before/after contrast drawn by management, real recent repeated events, and fresh with payoff ahead. We need to examine the transcript. The company is Clearside Biomedical, discussing CLS-AX, a treatment for retinal diseases delivered via suprachoroidal injection. The call reports OASIS Phase 1/2a data and interim extension data. The key is whether management draws a contrast between past claims/promises and now demonstrated capability. Look for management's own words. George Lasezkay says: "Today we are going to focus on our CLS-AX data... We are very pleased to report the data today from the OASIS trial... we are very encouraged by the durability data that has emerged... this data gives us very high confidence to move ahead with future CLS-AX clinical trials." Tom Ciulla discusses results. Is there a before/after contrast? They say they chose sub-responders to see biologic effect. They talk about safety and durability. But is there a phrase like "a year ago this was a concept"? Management doesn't explicitly contrast past claims vs now demonstrating. However, the question allows for "unmistakable from how management frames the change". For example, they might say "we have now shown" vs "we intended to show". But does management draw that line? They emphasize that this is first-in-man, they have safety and durability data. But is it a crossing from claiming to demonstrating? They have completed a Phase 1/2a trial. That is a demonstration of safety and biologic effect. However, the after-side must be "real, recent, and repeated" – meaning more than one instance. The trial had multiple patients, but that's not necessarily a repeated capability in the sense of ongoing operations. The question is about a capability, offering, or way of doing business that was a promise, plan, or early attempt and now is actually done more than once. Here, the capability is delivering CLS-AX via suprachoroidal injection. They have done it in multiple patients (all cohorts). Management is presenting that they have demonstrated safety and durability. But is management drawing a before/after contrast? They might say "we previously only had preclinical data, now we have clinical data".
NO Fresh order-of-magnitude reference change: management has started describing the business in units it did not use to nee
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the company's own unit of account has visibly changed. The transcript is about Clearside Biomedical, a biopharma company. They are discussing clinical trial results for CLS-AX, a drug candidate. The company's business is developing drugs. The "unit of account" would be things like number of patients, doses, trials, etc. The question asks if management now routinely describes its business in a larger denomination than before, and if this change is recent and driven by real business. Looking at the transcript, management discusses the OASIS trial, which is a Phase 1/2a clinical trial. They talk about cohorts, patients, doses. They mention "four dosing cohorts", "16 patients", "12 patients", etc. They also discuss the Extension Study with 8 patients. The numbers are small, typical for early-stage clinical trials. There is no indication that they are now talking about larger units like thousands of patients or commercial sales. They are still in clinical development. The company's cash runway is into 2024, and they are planning a Phase 2 trial. So the scale of operations is still small, typical for a clinical-stage biotech. The question asks if the company's own unit of account has visibly changed — meaning they now describe their business in larger denominations. For example, if they used to talk about individual patients and now talk about hundreds of patients, or if they used to talk about a single trial and now talk about multiple programs. But here, they are still talking about a single trial with a small number of patients. The numbers are not larger than before; they are just reporting results. There is no indication that the company has moved to a larger scale of operations. They are still in early-stage trials. Also, the shift must be recent and anchored in real current activity. The company is still in Phase 1/2a, so the scale is small. There is no mention of moving to commercial scale or larger units. The management does not say anything like "we now think in terms of thousands of patients" or "we now have multiple commercial products." They are still planning trials. Thus, the answer is NO. We need to be careful: the question is about the company's own unit of account, not about the industry. The company is a biotech, so its unit of account is patients, doses, trials. They are still in small numbers. No shift.
NO The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys that the company has recently finished the heavy phase of a major undertaking and is now in the collecting phase, with results still reflecting the paying phase. The transcript is about Clearside Biomedical's Q3 2022 earnings call, focusing on CLS-AX Phase 1/2a OASIS trial results. The heavy phase here is the clinical trial development, specifically the OASIS trial and extension study. Management discusses the data, safety, durability, and future plans. They say they are planning for Phase 2 trial. The OASIS trial is essentially done – they have final data from all four cohorts for three-month endpoint, and interim data from Extension Study. They expect to report final Extension data in Q1 2023. So the heavy phase (Phase 1/2a trial) is substantially complete. The collecting phase? The payoff would be future revenue from a drug, but that's not yet begun. They are in early clinical development, no product on market. The company has no approved product for CLS-AX. They have XIPERE but that's a different product. The "collecting" phase would be revenue from sales, but CLS-AX is not yet approved. So the benefit is not arriving yet. The call is about reporting trial results, not about collecting revenue. The heavy phase is the clinical trial, which is done, but the payoff is not beginning. The question asks: "the expensive, uncertain, or heavy phase of a major undertaking — the part that consumed money, time, and organizational energy — and has now entered the phase where the company COLLECTS on that completed work, with the reported results still mostly reflecting the paying phase rather than the collecting phase?" The "collects" could mean receiving benefits like data, regulatory milestones, or future revenue. But here, they have collected data, but the financial payoff is not yet. The company is still in development. They are planning Phase 2. So the heavy phase is not fully done; they still have more clinical trials ahead. The OASIS trial is complete, but that's just one part. The major undertaking of developing CLS-AX is still ahead. So management is not saying the heavy phase is behind them. They are saying they are encouraged and moving forward. They still have to do Phase 2 and Phase 3. So the answer is NO. Check if management conveys that the expensive phase is done and they are now collecting.
NO Old money out, new money in: the company is redirecting its own capital away from what it has always done and into a spe
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need analyze transcript. Question: Does management describe that company's own capital/operating resources are being redirected somewhere different than historically, with visible already-executing redirection, destination identifiable and funded at real scale, something getting less, management treats as defining, numbers still old allocation. We need use only transcript. Company Clearside Biomedical, developing CLS-AX via suprachoroidal injection. Historically? They have XIPERE launched for uveitic macular edema, SCS Microinjector. On call focus on CLS-AX Phase 1/2a OASIS data. They are planning Phase 2 trial in Q1 2023. Do they describe reallocation of resources away from something? They mention XIPERE commercially accepted, but not that they are shifting away. They have cash runway into 2024. They are actively planning Phase 2. But is there a visible redirection of incremental money, capacity, people, attention into CLS-AX and away from XIPERE? Management doesn't explicitly say they are reducing investment in XIPERE or legacy. They may be a development-stage company with multiple programs. Need see if they describe "company's own capital and operating resources now being pointed somewhere different than historically." Historically they had XIPERE (suprachoroidal space injection for uveitic macular edema) approved and commercialized via partner? Actually Clearside developed SCS Microinjector and XIPERE. Now they are focusing on CLS-AX. But do they say resources are being shifted? They say "We are actively planning for the initiation of a randomized controlled Phase 2 clinical trial in the first quarter of 2023" and "we will be able to further refine our financial runway once we finalize our plans." They have cash runway into 2024. They are investing in CLS-AX. But is something getting less? They don't mention reducing XIPERE or other programs. They might have historically spent on XIPERE commercialization? But no mention of winding down. They may have multiple pipeline. The question asks "THE COMPANY'S OWN CAPITAL AND OPERATING RESOURCES ARE NOW BEING POINTED SOMEWHERE DIFFERENT THAN THEY HISTORICALLY WENT" with visible redirection. Management does not describe reallocation away from anything. They just present CLS-AX data and future plans. No mention of shifting resources from XIPERE or other activities.
NO Cheap-to-serve incremental business: management says the next tranche of volume costs it almost nothing extra
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the transcript conveys that the cost of serving the next increment of business has become unusually low, with an already-built and paid-for base, and that additional business is already arriving. The company is Clearside Biomedical, a biopharma developing CLS-AX for retinal diseases. The call discusses OASIS trial results, safety, durability, and plans for Phase 2. They mention financial runway into 2024. They have a proprietary SCS Microinjector, already commercially accepted for XIPERE. They are planning a Phase 2 trial. Key points: They have a delivery system already developed and approved. They have a drug candidate. They are planning trials. But is there additional business arriving? The company is a development-stage biopharma, not yet generating revenue from CLS-AX. They have XIPERE commercialized, but the call focuses on CLS-AX. They mention "commercially accepted by retina physicians following the launch of XIPERE" - that indicates the delivery system is already in use. But the question is about incremental business for the company. The company's product is CLS-AX, which is in trials. They are not selling it yet. The "business" here might be the clinical development program? Or the potential future sales? The question asks about "additional volume, customers, usage, orders, or activity" - for a biotech, that could be trial enrollment, or partnerships, or sales of XIPERE. But the call is about CLS-AX data. They mention they have a financial runway into 2024, and they are planning a Phase 2 trial. They are not yet generating revenue from CLS-AX. The already-built base could be the SCS Microinjector platform, which is already approved and used for XIPERE. But is additional business arriving? They are planning to initiate a Phase 2 trial, but that's not revenue. They have no product sales for CLS-AX. The company's current business is likely XIPERE sales, but the call doesn't discuss XIPERE sales or revenue. The call is about clinical data. There is no mention of increasing sales, orders, or customers. The only "activity" is clinical trial progress. The question asks if management conveys that the cost of serving the next increment of business is unusually low - meaning they have already built the infrastructure (e.g., the delivery system, the drug formulation) and can serve more without proportional cost.
NO Bought the seat, waiting for the ride: management describes a position already secured inside someone else's decision, w
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management convey that the company's near-term growth no longer depends on persuading anyone, because the decisions that govern it have already been made by others — and that the resulting activity has only just begun to reach the company? We need to check if the transcript conveys all three conditions: (1) decision is behind them, (2) company is preparing to deliver, (3) company is small relative to committed business and numbers don't show it yet. Let's analyze the transcript. The company is Clearside Biomedical, developing CLS-AX, a treatment for wet AMD. They have OASIS trial data. They are planning a Phase 2 trial. The question is about near-term growth depending on decisions already made by others. In the transcript, they talk about their product, their pipeline, their plans. They mention they have a financial runway into 2024. They are planning a randomized controlled Phase 2 trial. They are not talking about a committed business from customers or partners. They are a biotech company in clinical development. The "decisions" that govern growth are regulatory approvals, clinical trial results, etc. They are not yet at a stage where they have a product approved and being sold. They have XIPERE launched, but that's a different product. The transcript focuses on CLS-AX data and future trials. There is no mention of a committed business from a partner or customer that has already decided. They are still in clinical trials. So the decision is not behind them; they still need to win regulatory approval, etc. The company is not preparing to deliver a product to customers; they are preparing for clinical trials. The numbers don't show it yet because they haven't generated revenue from CLS-AX. But the essence is that they are a development-stage company, not one that has been "chosen" by a customer. The question is about a company that has already been selected, e.g., a contract manufacturer, a supplier, etc. Here, it's a biotech with a pipeline. So the answer is NO. We need to be careful: the question asks if management conveys that near-term growth no longer depends on persuading anyone. In the transcript, they are still persuading investors, regulators, etc. They are not saying that a decision has been made. They are planning trials. So NO. Thus answer is NO.
NO Bet-the-company financing already spent on hard assets that are nearly finished
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management describes the company as being in the last stretch before its biggest-ever productive thing switches on, with funding already raised/committed, the build large relative to company and nearly ready, and current numbers from smaller predecessor business. The transcript is about Clearside Biomedical, a biopharma company. They are developing CLS-AX, a treatment for retinal diseases. They have completed a Phase 1/2a trial (OASIS) and are planning a Phase 2 trial. They have cash of $53.4 million as of Sept 30, 2022, giving runway into 2024. They are planning to initiate a randomized controlled Phase 2 trial in Q1 2023. The question is about a "productive thing" that is large relative to the company, funded, nearly ready, and current numbers are from smaller predecessor. This sounds like a manufacturing plant or a major product launch. But here, the company is a biotech with a drug in development. The "big thing" might be the commercialization of a drug, but they are still in clinical trials. They have not yet received approval. The Phase 2 trial is not yet started. They are planning it. So the undertaking is still early - they are planning a Phase 2 trial, not at the end of a build. The funding is there for the trial, but the trial itself is not the "productive thing" that will generate revenue. The company is pre-revenue. The current activity is R&D. The "big thing" would be the eventual product launch, but that is far off. Management is not describing a funded, nearly complete build. They are describing early-stage clinical development. So answer NO. Check each condition: (1) Funding question behind them? They have cash for runway into 2024, but they are still planning the Phase 2 trial. They are not describing spending on a large build; they are describing planning. (2) Undertaking large relative to company and nearly ready? The Phase 2 trial is not large relative to the company in terms of output; it's a clinical trial. It's not nearly ready; it's about to start. (3) Today's numbers are not the company that is about to exist? The company is pre-revenue, so yes, but the "new thing" is not about to exist. The new thing is a drug that is years away from commercialization. Thus, the answer is NO. The transcript is about clinical trial results and future plans, not about a funded, nearly complete build.
NO Deliberately different by design: management explains how the company operates unlike its industry's standard playbook,
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management describes the company as deliberately operating differently from the standard way its industry works, and credits that difference as a real driver of current business results. The transcript is about Clearside Biomedical, a biopharma company developing CLS-AX, a treatment for retinal diseases. The call discusses OASIS trial results, safety, durability, etc. Key points: They use a suprachoroidal delivery via SCS Microinjector, which is FDA approved for XIPERE. They emphasize that this delivery method is different from intravitreal injections used by competitors. They also mention that they chose a difficult patient population (sub-responders) to test their drug, which is different from typical trials. They also discuss that their drug is a TKI (axitinib) which is more potent and pan-VEGF inhibition, different from anti-VEGF agents. But the question is about operating differently from the industry's standard way in terms of business model, building, selling, pricing, serving, sourcing, staffing, or organizing. The transcript focuses on clinical trial design and drug delivery method. The delivery method (suprachoroidal vs intravitreal) is a difference in how the drug is administered, which is a technical difference in the product, not necessarily a business model difference. However, it could be seen as a different way of delivering the therapy. But does management explicitly contrast with industry normal practice? They mention that the SCS Microinjector is commercially accepted and that they are using it. They also mention that they chose a difficult patient population to test, which is a deliberate choice in trial design, but that's not about how the company operates in the market. The question asks: "does management describe the company as DELIBERATELY OPERATING DIFFERENTLY FROM THE STANDARD WAY ITS INDUSTRY WORKS — identifying a specific, chosen difference in how the company builds, sells, prices, serves, sources, staffs, or organizes itself that departs from what management presents as the normal practice of its competitors or industry — AND does management credit that chosen difference as a real driver of business results the company is achieving RIGHT NOW?" We need to see if management explicitly contrasts their approach with industry norms and attributes current success to that difference.
NO Inheritance being cashed in: management is converting a long-held position into current business on purpose
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the company is deliberately converting something it has long held or built into current business, with real present-tense business already coming from it, and management conveying that this conversion is still early relative to what the holding can yield. The transcript is about Clearside Biomedical, a company developing CLS-AX, a treatment for wet AMD. They have a proprietary SCS Microinjector, which is already commercially approved for XIPERE. The company is now using this delivery system for CLS-AX. The key point: they have a long-held asset - the SCS Microinjector technology, which was developed and approved for XIPERE. Now they are leveraging it for CLS-AX, a new drug. The OASIS trial data shows promising results. Management is planning a Phase 2 trial. The conversion is deliberate: they are using the existing delivery system to develop a new product. The business already producing: they have XIPERE launched, and now CLS-AX is in trials. But is the conversion already producing real business? The company is still in clinical trials for CLS-AX, not yet commercial. However, the SCS Microinjector is already commercially used for XIPERE. But the question is about converting a long-held asset into current business. The company has the SCS Microinjector, which is approved and used. They are now using it for CLS-AX. But is that a conversion? They are building on existing technology. The holding predates: the SCS Microinjector was developed earlier. The conversion is deliberate: they are using it for a new indication. But is the yield still ahead? Yes, CLS-AX is in Phase 2, so the big yield is ahead. However, the current business from the holding is XIPERE, which is already commercial. But the question is about converting something long held into current business. The company is not really "cashing in" on the SCS Microinjector in a new way; they are using it as a platform for new drugs. That might be considered a conversion. But the transcript focuses on CLS-AX data, not on monetizing the delivery system. Management does not explicitly say "we are now drawing on our long-held SCS Microinjector to generate business." They mention that the SCS Microinjector is commercially accepted, but the main discussion is about CLS-AX. The company is not selling the delivery system separately; it's part of their product.
NO The streak is alive: management narrates back-to-back quarters of the same improvement and shows this quarter extended i
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management presents the just-reported period as the latest step in an unbroken, still-running sequence of quarter-after-quarter improvement in the same part of the business, explicitly connecting this period to the immediately preceding period or periods as one continuing climb, with real current-period evidence. The transcript is about Clearside Biomedical's Q3 2022 earnings call, focusing on CLS-AX clinical trial data. The business is a biotech developing treatments for retinal diseases. The "part of the business" could be the progress of the CLS-AX program, but the question asks about "improvement" in a business metric like orders, customers, volumes, etc. Here, the improvement is in clinical trial results, durability, safety, etc. But the question is about "quarter-after-quarter improvement in the same part of the business" - likely referring to financial or operational metrics. However, the transcript is mostly about clinical data, not financial performance. The financial part is minimal: they reported cash position and runway. There is no mention of sequential improvement in revenue, sales, etc. The company is a clinical-stage biotech with no product revenue. So there is no quarter-over-quarter improvement in business metrics. The only "improvement" is in clinical trial data, but that is not a business metric like orders or customers. The question specifically says "the same part of the business" and gives examples like orders, customers, volumes, output, utilization, activity, bookings, profitability, or the performance of a particular product, operation, or market. Clinical trial results could be considered "performance of a particular product" but the question requires a sequence of consecutive periods with improvement. Here, the trial is ongoing, but the data is from a single trial with multiple cohorts. The management does not frame it as a sequence of quarters improving. They present the OASIS trial data as a single study with results. There is no mention of "another quarter of growth" or "fourth consecutive quarter" etc. The only sequential aspect is the extension study, but that is not a business improvement. The financial part: they say cash runway into 2024, but no sequential improvement. Thus, the answer is NO. Management does not present a quarter-after-quarter improvement sequence.
NO Skeptical premise dismantled with receipts: the call's central doubt is answered by named, checkable current facts
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if there is a specific doubt about the company that is live in the conversation, and whether management answers it with named, checkable facts from the recent period that run against it. The doubt should be company-specific, not generic. The answer should be YES if both halves come through. Looking at the transcript: The company is Clearside Biomedical, developing CLS-AX for wet AMD. The OASIS trial data is presented. The doubt could be about the durability or efficacy of CLS-AX, or about the company's ability to compete. But the call is mostly about presenting positive data. Analysts ask questions about trial design, patient selection, endpoints, etc. There is no explicit doubt expressed by analysts or management about a specific concern that is being rebutted with concrete facts. The company is presenting data and answering questions. The doubt might be about the off-protocol retreatments, but management explains that these were due to investigator caution, not lack of efficacy. They provide case studies and data showing stability. However, the doubt is not a standing market doubt that is being directly rebutted with checkable facts. The company is not addressing a known skepticism with concrete evidence of, say, customers renewing or demand holding. This is a biotech clinical trial update. The doubt could be about the durability of the drug, but the answer is based on interim data, not yet fully realized. The company is confident and plans to move forward. The doubt is not clearly identified as a market concern. The call is more of a data presentation. So likely answer is NO. But let's check: Is there a specific doubt? The analysts ask about the off-protocol treatments, and management explains that the independent reading center did not verify the rationale. They also discuss the patient population being sub-responders. The doubt might be that the drug doesn't work, but the data shows it does. However, the rebuttal is not with named, checkable facts from the recent period that are already realized and continuing. The facts are the trial results themselves, which are the subject of the call. The doubt is not a pre-existing market doubt that is being addressed with concrete operational facts like customer retention. The transcript is about a clinical trial, so the doubt is about efficacy and safety.
NO Staircase quarter: best recent period just reported, and the next step up is already in hand
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management presents the just-reported period as one of the strongest stretches in recent history, and also says the next period will be bigger, based on things already in hand. Let's analyze the transcript. The company is Clearside Biomedical, a biotech. The call is about Q3 2022 earnings and OASIS trial data. The focus is on clinical trial results, not typical business metrics like orders or revenue. The "business" here is the development of CLS-AX, a drug candidate. The "period just finished" could be the OASIS trial results, or the quarter. But the question asks about "business" in terms of orders, volumes, customers, activity, output, wins, or overall performance. For a biotech, that might be clinical progress, data readouts, etc. Management says: "We are very pleased to report the data today from the OASIS trial... we saw a very favorable safety profile... we are very encouraged by the durability data... CLS-AX provided at least 73% reduction in treatment burden... Further, the OASIS study demonstrated both a stable mean best corrected visual acuity and a stable mean central subfield thickness... This data gives us very high confidence to move ahead with future CLS-AX clinical trials." So they are positive about the data. But is it described as the strongest stretch in recent history? They don't explicitly say "this is the best we've ever had" or "record". They say "very encouraged", "high confidence". It's a positive data readout, but not necessarily framed as a high-water mark versus the company's own past. The company is a clinical-stage biotech, so the "business" is about pipeline progress. The OASIS data is a milestone, but they don't compare it to previous periods as the strongest. Now, the next period: They say "We expect to report the final Extension Study data in the first quarter of 2023." and "We are actively planning for the initiation of a randomized controlled Phase 2 clinical trial in the first quarter of 2023". So the next period (Q1 2023) will have Phase 2 initiation and final extension data. Is that described as bigger? They don't say it will be bigger than the just-reported period. They just say they are planning. They don't say "the next quarter will be even stronger" or "we have already secured something". The step-up is not described as already in hand; it's planning.
Showing the latest 18 of 233 archived research questions.
These archived questions are separate from the newer 500-check scan above.
CLSD call history
Open a quarter only when you want its detailed evidence.
C Q3 2023 · Caution · 2023-11-13Management gave no formal guidance. The delivery was rich in specifics, promotional in tone.
F Q2 2023 · Very weak call · 2023-08-14Management gave no formal guidance. The delivery was rich in specifics, promotional in tone.
View the 20 core call-quality checks
D Q1 2023 · Weak call · 2023-05-11Management gave no formal guidance. The delivery was rich in specifics.
View the 20 core call-quality checks
C Q4 2022 · Caution · 2023-03-09Management held guidance steady.
View the 20 core call-quality checks
C Q3 2022 · Caution · 2022-11-09Management gave no formal guidance. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
D Q2 2022 · Weak call · 2022-08-09Management gave no formal guidance. The delivery was rich in specifics, promotional in tone.
View the 20 core call-quality checks
C Q1 2022 · Caution · 2022-05-11Management gave no formal guidance. The delivery was unusually candid, rich in specifics, promotional in tone.
View the 20 core call-quality checks
View 19 earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|---|---|---|---|---|---|---|
| Q4 2021 | 2022-03-10 | B | none | unclear | unclear | 7/9 | 2/9 |
| Q3 2021 | 2021-11-10 | B | raised | stable | unclear | 7/9 | 3/9 |
| Q2 2021 | 2021-08-10 | D | maintained | unclear | unclear | 6/9 | 4/9 |
| Q1 2021 | 2021-05-17 | C | none | unclear | unclear | 6/9 | 2/9 |
| Q4 2020 | 2021-03-10 | C | none | unclear | unclear | 7/9 | 2/9 |
| Q3 2020 | 2020-11-10 | C | maintained | unclear | unclear | 6/9 | 2/9 |
| Q2 2020 | 2020-08-10 | D | none | unclear | unclear | 7/9 | 3/9 |
| Q4 2019 | 2020-03-11 | C | maintained | stable | unclear | 7/9 | 3/9 |
| Q3 2019 | 2019-11-10 | C | none | unclear | contracting | 7/9 | 2/9 |
| Q2 2019 | 2019-08-07 | D | none | unclear | contracting | 7/9 | 4/9 |
| Q1 2019 | 2019-05-08 | D | none | unclear | contracting | 6/9 | 4/9 |
| Q4 2018 | 2019-03-12 | C | none | unclear | contracting | 6/9 | 4/9 |
| Q3 2018 | 2018-11-10 | C | none | unclear | contracting | 7/9 | 4/9 |
| Q2 2018 | 2018-08-08 | C | maintained | unclear | contracting | 6/9 | 4/9 |
| Q1 2018 | 2018-05-12 | C+ | maintained | unclear | unclear | 6/9 | 3/9 |
| Q4 2017 | 2018-03-14 | C | none | unclear | contracting | 6/9 | 3/9 |
| Q3 2017 | 2017-11-08 | D | none | unclear | contracting | 5/9 | 4/9 |
| Q2 2017 | 2017-08-09 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q1 2017 | 2017-05-10 | C | none | unclear | unclear | 6/9 | 4/9 |